MedPath

APO-IRBESARTAN/HCTZ

APO-IRBESARTAN/HCTZ

Dormant
DIN Number

02387646

Drug Class

Human

Market Date

Feb 26, 2013

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02387646
AIG Number0240086001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA04 IRBESARTAN AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE
IRBESARTANActive
Strength: 150 MG
Monograph: IRBESARTAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.